{
  "id": "45585b65e20b246e",
  "title": "Flagship-Backed Drug Firm Generate Biomedicines Files for US IPO",
  "description": "Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector.",
  "content": "Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector.",
  "source": "Bloomberg Markets",
  "source_url": "https://www.bloomberg.com/news/articles/2026-02-04/flagship-backed-drug-firm-generate-biomedicines-files-for-us-ipo",
  "published_at": "2026-02-04T22:46:50+00:00",
  "fetched_at": "2026-02-05T00:29:17.336486+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [
    "drug",
    "ipo"
  ],
  "location": null,
  "raw_data": {
    "title": "Flagship-Backed Drug Firm Generate Biomedicines Files for US IPO",
    "description": "Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector.",
    "url": "https://www.bloomberg.com/news/articles/2026-02-04/flagship-backed-drug-firm-generate-biomedicines-files-for-us-ipo",
    "published": "2026-02-04T22:46:50+00:00",
    "source": "Bloomberg Markets"
  }
}